Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

PWRM, KIM, GNK, TE Stock Alert DoubleInStocks.com Reports

money 1
signup3m

power3 PWRM, Power 3 Medical Products Inc., PWRM.OB

PWRM is a leader in bio-medical research and the commercialization of neurodegenerative disease and cancer biomarkers, pathways, and mechanisms of diseases through the development of diagnostic tests and drug targets.

PWRM’s patent-pending technologies are being used to develop screening and diagnostic tests for the early detection and prognosis of disease, identify protein biomarkers, drug targets, and its diagnostic tests are targeted toward markets with critical unmet needs in areas including neurodegenerative disease (NuroPro) and breast cancer (BC-SeraPro).

PWRM continues to evolve and enhance its IP portfolio, employing sensitive and specific combinations of biomarkers it has discovered from a broad range of diseases as the basis of highly selective blood-based tests for ALS (Lou Gehrig’s disease), Alzheimer’s, Parkinson’s diseases, breast cancer, and drug resistance.

The NuroPro Blood Test is PWRM’s diagnostic tool for the early detection of Neurodegenerative diseases. The analysis is designed as a tool for physicians to diagnose various degenerative diseases of the brain and nervous system. The test involves monitoring the concentration of 59 proteins in blood serum to accurately detect and distinguish between Alzheimer’s disease, ALS (Lou Gehrig’s disease), and Parkinson’s disease .

PWRM’s BC-SeraPro(NYSE:TM) is a proteomic test for the diagnosis of breast cancer. This test is designed to measure the quantitative expression level of 22 protein biomarkers in the serum that differentiate between breast cancer patients and control subjects. The level of the biomarkers from the patient’s serum sample is compared to PWRM’s patient database. Statistical analysis by linear discriminant function will analyze the biomarker levels of the patient sample and assign a probability score for the diagnosis. Probability score is ranged from 0.0 to 1.0. Results of PWRM’s BC-SeraPro(TM) test should not be considered a stand alone diagnosis nor a guarantee and is intended to be used in conjunction with mammography and other accepted modalities.

PWRM expects to complete phase II clinical validation trials of its blood serum diagnostics for Alzheimer’s disease (NuroPro-AD), Parkinson’s disease (NuroPro-PD) and breast cancer in 2010, followed by filings with the FDA.

www.power3medical.com

****

Kimco Realty Corporation (NYSE:KIM) reported results for the quarter ended September 30, 2010. Announced a 12.5 percent increase to the quarterly common dividend to $0.18 per common share; Generated funds from operations (FFO) of $0.27 per diluted share; recurring FFO of $0.28 per diluted share; Reported a 2.2 percent increase in U.S. same-property net operating income (NOI) compared to the third quarter of 2009; Closed the quarter with occupancy of 92.7 percent in its combined shopping center portfolio and 92.3 percent in the U.S. portfolio; Reported positive U.S. cash-basis leasing spreads of 1.5 percent on 282 new leases, renewals and options signed totaling 0.9 million square feet.

Kimco Realty Corporation is a publicly owned real estate investment trust. The firm engages in acquisitions, development, and management of neighborhood and community shopping centers. It also provides property management services relating to the management, leasing, operation, and maintenance of real estate properties.

****

Genco Shipping & Trading Ltd. (NYSE:GNK) reported its financial results for the three and nine months endedSeptember 30, 2010. Recorded net income attributable to Genco for the third quarter of$36.2 million, or $1.07 basic and $0.99 diluted earnings per share; announced entered into the $100 million secured credit facility to finance the vessels acquired from Metrostar onAugust 12, 2010; Entered into the $253 million secured credit facility to finance the vessels acquired from Bourbon onAugust 20, 2010; Completed the closing of a concurrent $125 million convertible note offering and $57.5 million follow-on common stock offering including over-allotment options exercised by the underwriters on July 27, 2010.

Genco Shipping & Trading Limited engages in the ocean transportation of drybulk cargoes through the ownership and operation of drybulk carrier vessels worldwide. It primarily transports iron ore, coal, grain, steel products, and other drybulk cargoes.

****

TECO Energy, Inc. (NYSE:TE) announced that team members from TECO Energy, Tampa Electric and Peoples Gas have completed an entirely new TECO Energy “storefront” at the Bill Poe Family Junior Achievement Center, home of the Pam and Les Muma JA BizTown. The new storefront gives a whole new look to the workplace for fifth graders who will develop business skills there this school year. JA BizTown, an education center in north Tampa, is a Junior Achievement program that lets children get to know the business world by working in storefronts of companies including TECO Energy, Bank of America, Publix and others.

TECO Energy, Inc., through its subsidiaries, engages in the generation, purchase, transmission, distribution, and sale of electric energy in Florida. The company provides retail electric service in West Central Florida.

 

 

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DoubleInStocks.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. (Read more at: http://doubleinstocks.com/disclaimer) Release of Liability: Through use of this website viewing or using, you agree to hold DoubleInStocks.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services from Power 3 Medical Products Inc. (OTC:PWRM).

Sign Up for our FREE Daily Stock Newsletter

http://doubleinstocks.com/img/doubleinstocks_buscard.jpg



Disclosure: none